NCT00001909View on ClinicalTrials.gov

Phase II Efficacy Study of Aerosolized Recombinant Human IL-4 Receptor in Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 31, 1999

Study Completion Date

May 31, 2000

Conditions
AsthmaHypersensitivity
Interventions
DRUG

Soluble recombinantly produced IL-4R

Trial Locations (1)

20892

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00001909 - Phase II Efficacy Study of Aerosolized Recombinant Human IL-4 Receptor in Asthma | Biotech Hunter | Biotech Hunter